research Telogen Effluvium: A Sequela of COVID-19
COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.
Search
for
Sort by
Research
240-270 / 1000+ results 
research Telogen Effluvium Associated with COVID-19 Infection
COVID-19 may cause hair loss due to infection stress or treatments.
research Teledermatology in the COVID-19 Pandemic: A Systematic Review
Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.
research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management
COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.
research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium
Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.
research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign
AGA linked to worse COVID-19 outcomes in men.
research Male Balding Is a Major Risk Factor for Severe COVID-19
Men with severe balding have a higher risk of getting very sick from COVID-19.
research Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19
Women with high androgen levels may have more severe COVID-19 symptoms.
research Alopecia and Grey Hair Are Associated with COVID-19 Severity
Having a lot of gray hair and hair loss are linked to more severe COVID-19.
research Dermatologic Manifestations of COVID-19: A Comprehensive Systematic Review
COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.
research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation
COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.
research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium
COVID-19 infection can significantly cause temporary hair loss.
research Dermatological Manifestations Associated with COVID-19: A Comprehensive Review of the Current Knowledge
COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.
research A Concomitant Diagnosis of COVID-19 Infection and Systemic Lupus Erythematosus Complicated by a Macrophage Activation Syndrome: A New Case Report
COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.
research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients
COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.
research COVID-19 Clinical Outcomes and Nationality: Results from a Nationwide Registry in Kuwait
Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.
research Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.
research Safety and Efficacy of the COVID-19 Vaccine in Children and Adolescents: A Meta-Analysis
COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.
research A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19
More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.
research Androgen Deprivation Therapy May Be a More Effective COVID-19 Prophylactic Than Therapeutic Strategy
Androgen deprivation therapy might be better for preventing COVID-19 than treating it.
research Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.
research Mild-To-Moderate COVID-19 Is Not Associated With Worsening Of Alopecia Areata: A Retrospective Analysis Of 32 Patients
COVID-19 doesn't make alopecia areata worse.
research COVID-19: The Experience from Iran
Timely and coordinated efforts are crucial in managing a public health crisis like COVID-19.
research Presentation and Management of Cutaneous Manifestations of COVID-19
COVID-19 can cause various skin symptoms that usually improve with proper treatment.
research A Systematic Review of Dermatologic Manifestations Among Adult Patients With COVID-19 Diagnosis
COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.
research Impact of Androgen Deprivation Therapy on Mortality of Prostate Cancer Patients with COVID-19: A Propensity Score-Based Analysis
Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.
research Androgenetic Alopecia May Be Associated With Weaker COVID-19 T-Cell Immune Response: An Insight Into a Potential COVID-19 Vaccine Booster
Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.
research Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity
COVID-19 patients may experience hair loss, but it's not linked to their age or sex.
research Case Report: Rowell Syndrome-Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.
research Recovery From Alopecia After COVID-19
A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.